|
1
|
Nevskaya AA, Purgatorio R, Borisova TN, Varlamov AV, Anikina LV, Obydennik AY, Nevskaya EY, Niso M, Colabufo NA, Carrieri A, Catto M, de Candia M, Voskressensky LG, Altomare CD. Nature-Inspired 1-Phenylpyrrolo[2,1- a]isoquinoline Scaffold for Novel Antiproliferative Agents Circumventing P-Glycoprotein-Dependent Multidrug Resistance. Pharmaceuticals (Basel) 2024; 17:539. [PMID: 38675499 PMCID: PMC11054433 DOI: 10.3390/ph17040539] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 03/06/2024] [Revised: 04/09/2024] [Accepted: 04/15/2024] [Indexed: 04/28/2024] Open
Abstract
Previous studies have shown that some lamellarin-resembling annelated azaheterocyclic carbaldehydes and related imino adducts, sharing the 1-phenyl-5,6-dihydropyrrolo[2,1-a]isoquinoline (1-Ph-DHPIQ) scaffold, are cytotoxic in some tumor cells and may reverse multidrug resistance (MDR) mediated by P-glycoprotein (P-gp). Herein, several novel substituted 1-Ph-DHPIQ derivatives were synthesized which carry carboxylate groups (COOH, COOEt), nitrile (CN) and Mannich bases (namely, morpholinomethyl derivatives) in the C2 position, as replacements of the already reported aldehyde group. They were evaluated for antiproliferative activity in four tumor cell lines (RD, HCT116, HeLa, A549) and for the ability of selectively inhibiting P-gp-mediated MDR. Lipophilicity descriptors and molecular docking calculations helped us in rationalizing the structure-activity relationships in the P-gp inhibition potency of the investigated 1-Ph-DHPIQs. As a main outcome, a morpholinomethyl Mannich base (8c) was disclosed which proved to be cytotoxic to all the tested tumor cell lines in the low micromolar range (IC50 < 20 μM) and to inhibit in vitro the efflux pumps P-gp and MRP1 responsible for MDR, with IC50s of 0.45 and 12.1 μM, respectively.
Collapse
Affiliation(s)
- Alisa A. Nevskaya
- Organic Chemistry Department, RUDN University, 6 Miklukho-Maklaya St, Moscow 117198, Russia; (A.A.N.); (A.V.V.); (A.Y.O.); (L.G.V.)
| | - Rosa Purgatorio
- Department of Pharmacy-Pharmaceutical Sciences, University of Bari Aldo Moro, Via E. Orabona 4, 70125 Bari, Italy; (R.P.); (M.N.); (N.A.C.); (A.C.); (M.d.C.)
| | - Tatiana N. Borisova
- Organic Chemistry Department, RUDN University, 6 Miklukho-Maklaya St, Moscow 117198, Russia; (A.A.N.); (A.V.V.); (A.Y.O.); (L.G.V.)
| | - Alexey V. Varlamov
- Organic Chemistry Department, RUDN University, 6 Miklukho-Maklaya St, Moscow 117198, Russia; (A.A.N.); (A.V.V.); (A.Y.O.); (L.G.V.)
| | - Lada V. Anikina
- Institute of Physiologically Active Compounds of the FSBIS of the Federal Research Center for Problems of Chemical Physics and Medicinal Chemistry of the RAS, 1 SevernyiProezd, Chernogolovk 142432, Russia;
| | - Arina Yu. Obydennik
- Organic Chemistry Department, RUDN University, 6 Miklukho-Maklaya St, Moscow 117198, Russia; (A.A.N.); (A.V.V.); (A.Y.O.); (L.G.V.)
| | - Elena Yu. Nevskaya
- General and Inorganic Chemistry Department, RUDN University, 6 Miklukho-Maklaya St, Moscow 117198, Russia;
| | - Mauro Niso
- Department of Pharmacy-Pharmaceutical Sciences, University of Bari Aldo Moro, Via E. Orabona 4, 70125 Bari, Italy; (R.P.); (M.N.); (N.A.C.); (A.C.); (M.d.C.)
| | - Nicola A. Colabufo
- Department of Pharmacy-Pharmaceutical Sciences, University of Bari Aldo Moro, Via E. Orabona 4, 70125 Bari, Italy; (R.P.); (M.N.); (N.A.C.); (A.C.); (M.d.C.)
| | - Antonio Carrieri
- Department of Pharmacy-Pharmaceutical Sciences, University of Bari Aldo Moro, Via E. Orabona 4, 70125 Bari, Italy; (R.P.); (M.N.); (N.A.C.); (A.C.); (M.d.C.)
| | - Marco Catto
- Department of Pharmacy-Pharmaceutical Sciences, University of Bari Aldo Moro, Via E. Orabona 4, 70125 Bari, Italy; (R.P.); (M.N.); (N.A.C.); (A.C.); (M.d.C.)
| | - Modesto de Candia
- Department of Pharmacy-Pharmaceutical Sciences, University of Bari Aldo Moro, Via E. Orabona 4, 70125 Bari, Italy; (R.P.); (M.N.); (N.A.C.); (A.C.); (M.d.C.)
| | - Leonid G. Voskressensky
- Organic Chemistry Department, RUDN University, 6 Miklukho-Maklaya St, Moscow 117198, Russia; (A.A.N.); (A.V.V.); (A.Y.O.); (L.G.V.)
| | - Cosimo D. Altomare
- Department of Pharmacy-Pharmaceutical Sciences, University of Bari Aldo Moro, Via E. Orabona 4, 70125 Bari, Italy; (R.P.); (M.N.); (N.A.C.); (A.C.); (M.d.C.)
| |
Collapse
|
|
2
|
Abstract
Pyrrolo[2,1-a]isoquinolines occur frequently in a large number of bioactive natural products and pharmaceutically important molecules. The synthesis of pyrrolo[2,1-a]isoquinoline derivatives is an easy and useful way to produce artificial molecules with potential applications. A huge number of excellent methodologies for constructing pyrrolo[2,1-a]isoquinolines have been reported in the last decade. This review summarizes the recent advances in this research field covering from 2011 to 2021.
Collapse
Affiliation(s)
- Hai-Lei Cui
- Laboratory of Asymmetric Synthesis, Chongqing University of Arts and Sciences, 319 Honghe Ave., Yongchuan, Chongqing, 402160, PR China.
| |
Collapse
|